Abbott India
Ticker >

Abbott India share price

Abbott India Ltd.

NSE: ABBOTINDIA BSE: 500488 SECTOR: Pharmaceuticals & Drugs  125k   952   129

22858.00
-215.40 (-0.93%)
NSE: 08 Dec 03:57 PM

Price Summary

Today's High

₹ 23150

Today's Low

₹ 22728.65

52 Week High

₹ 24744.25

52 Week Low

₹ 19900

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 48571.65 Cr.

Enterprise Value

₹ 46634.59 Cr.

No. of Shares

2.12 Cr.

P/E

44.91

P/B

15.62

Face Value

₹ 10

Div. Yield

1.42 %

Book Value (TTM)

₹  1463.07

CASH

₹ 1937.06 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

74.99 %

EPS (TTM)

₹  508.93

Sales Growth

8.86%

ROE

32.07 %

ROCE

42.93%

Profit Growth

18.87 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Abbott India Ltd.

BRUFEN Digene DUPHALAC Zolfresh Cremaffin Solspre Cremalax Ganaton LIBRAX THYROCAB Eptoin OBIMET SOLFE Wymox

Index Presence

The company is present in 29 Indices.

NIFTYMNC

Nifty MNC
23148.8
  -152.798828125 (-0.655743943276421%)

NFTALLO30

NIFTY Alpha Low-Volatility 30
22234.2
  -63.451171875 (-0.284564385768993%)

NMID150Q50

NIFTY Midcap150 Quality 50
19717.2
  -47.951171875 (-0.242604639617339%)

NIFTY500

Nifty 500
18703.5
  -0.349609375 (-0.00186918405730152%)

NFTALQVL30

NIFTY Alpha Quality Low-Volatility 30
18239.1
  39.9399999999987 (0.219460678404926%)

NIFTY200QLTY30

NIFTY200 Quality 30
17424.9
  -39.650390625 (-0.227033555695966%)

NIFTYMIDCAP150

Nifty Midcap 150
16447.95
  -31.900390625 (-0.193572097932571%)

NIFTYPHARMA

Nifty Pharma
16163.15
  -131.0498046875 (-0.804272705113818%)

NFTALQLV30

NIFTY Alpha Quality Value Low-Volatility 30
16096.39
  3.13999999999942 (0.0195112857875213%)

NIFTYMIDSMALL400

Nifty MidSmallcap 400
15404.05
  -65.8505859375 (-0.425669101123671%)

NFTQTLO30

NIFTY Quality Low-Volatility 30
14865.97
  31.0100000000002 (0.209033256577706%)

NIFTYLGEMID250

NIFTY LargeMidcap 250
12854.45
  -3.25 (-0.0252766820709072%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
12837
  -24.400390625 (-0.189717992472938%)

MIDCAP50

Nifty Midcap 50
12624.2
  -6.99980468750073 (-0.0554167829462049%)

NIFTYTOTALMCAP

Nifty Total Market index
10504.45
  -1 (-0.00951886860066642%)

NIFTYHEALTH

Nifty Healthcare Index
10287.7
  -50.9501953125 (-0.492812827472155%)

NIFTYMIDSELECT

Nifty Midcap Select
9974.75
  -0.150390625 (-0.00150769049425126%)

MIDCAP

S&P Bse Mid Cap
35290.91
  -56.679999999993 (-0.160350394468178%)

BSE HC

S&P Bse Healthcare
30335.71
  -176.060000000001 (-0.57702322742994%)

BSE500

S&P Bse 500
29581
  -3.40999999999985 (-0.011526341069501%)

MID150

S&P Bse 150 MidCap
12225.68
  -23.1599999999999 (-0.189079129125691%)

S&P MIDSMLCAP

S&P Bse MidSmallCap
10226.87
  46.6200000000008 (0.457945531789505%)

MSL400

S&P Bse 400 MidSmallCap
9343.05
  -33.9500000000007 (-0.362056094699803%)

BSE200

S&P Bse 200
9285.82
  5.94999999999891 (0.0641172775049492%)

LMI250

S&P Bse 250 LargeMidCap
8805.03
  4.84000000000015 (0.0549988125256418%)

S&P LARGEMIDCAP

S&P Bse Large MidCap
8735.29
  11.6100000000006 (0.133086037085284%)

ALLCAP

S&P Bse Allcap
8604.72
  -2.32999999999993 (-0.0270708314695556%)

SPBSLVIP

S&P Bse Low Volatility
1503.87
  -6.90000000000009 (-0.456720745050543%)

SPBSQIP

S&P Bse Quality
1467.65
  -13.27 (-0.896064608486613%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.86%
3 Year9.33%
5 Year10.15%

Profit Growth

1 Year18.87%
3 Year16.99%
5 Year18.8%

ROE%

1 Year32.07%
3 Year29.97%
5 Year28.33%

ROCE %

1 Year42.93%
3 Year40.33%
5 Year39.08%

Debt/Equity

0

Price to Cash Flow

54.37

Interest Cover Ratio

80.6635397123202

CFO/PAT (5 Yr. Avg.)

1.06059309458551

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2023 74.99 0
Jun 2023 74.99 0
Mar 2023 74.99 0
Dec 2022 74.99 0
Sep 2022 74.99 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 16.9903730283001% for the Past 3 years.
  • Company has been maintaining healthy ROE of 29.9670058657414% over the past 3 years.
  • Company has been maintaining healthy ROCE of 40.3272856647713% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 80.6635397123202.
  • The company has an efficient Cash Conversion Cycle of -44.7259058850113 days.
  • Company has a healthy liquidity position with current ratio of 2.50834148687418.
  • The company has a good cash flow management; CFO/PAT stands at 1.06059309458551.
  • The company has a high promoter holding of 74.99%.

 Limitations

  • The company has shown a poor revenue growth of 9.32798876598038% for the Past 3 years.
  • The company is trading at a high PE of 44.91.
  • The company is trading at a high EV/EBITDA of 30.4425.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
Net Sales 1379.33 1326.48 1343.08 1479 1494.14
Total Expenditure 1036.18 1009.99 1062.96 1124 1113.26
Operating Profit 343.15 316.49 280.12 355 380.88
Other Income 33.68 39.94 49.64 56 55.51
Interest 3.97 3.79 4.01 3.34 3.13
Depreciation 17.47 17.81 17.34 17.17 17.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 355.39 334.83 308.41 390.49 415.42
Tax 89.87 88 76.99 100.25 102.48
Profit After Tax 265.52 246.83 231.42 290.24 312.94
Adjusted EPS (Rs) 124.95 116.16 108.9 136.58 147.27

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 3678.6 4093.14 4310.02 4913.32 5348.73
Total Expenditure 3074.56 3336.96 3391.13 3831.74 4143.24
Operating Profit 604.05 756.18 918.89 1081.58 1205.49
Other Income 113.98 114.66 83.47 83.35 154.29
Interest 2.25 8.53 18.28 19.1 15.99
Depreciation 16.92 59.61 58.13 66.1 69.97
Exceptional Items 0 0 0 0 0
Profit Before Tax 698.85 802.7 925.95 1079.73 1273.82
Tax 248.52 209.77 235.26 281.03 324.41
Net Profit 450.33 592.93 690.69 798.7 949.41
Adjusted EPS (Rs.) 211.93 279.03 325.03 375.86 446.78

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 21.25 21.25 21.25 21.25 21.25
Total Reserves 1987.34 2410.45 2580.91 2798.54 3167.29
Borrowings 0 0 0 0 0
Other N/C liabilities 62.36 209.6 189.62 184.18 144.02
Current liabilities 856.89 891.11 1030.86 1203.19 1206.02
Total Liabilities 2927.84 3532.41 3822.64 4207.16 4538.58
Assets
Net Block 104.96 269.83 250.78 271 236.91
Capital WIP 0.73 1.64 0.66 0.66 3.66
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 56.69 50.91 78.8 79.35 97.88
Other N/C Assets 4.47 5.38 4.99 3.11 1175.02
Current Assets 2760.98 3204.65 3487.41 3853.04 3025.11
Total Assets 2927.84 3532.41 3822.64 4207.16 4538.58
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 698.85 802.7 925.95 1079.73 1273.82
Adjustment -77.46 -17.22 24.99 23.3 -62.7
Changes in Assets & Liabilities 134.41 69.82 11.26 133.62 23.13
Tax Paid -256.67 -229.17 -235.46 -288.99 -340.86
Operating Cash Flow 499.13 626.13 726.74 947.66 893.39
Investing Cash Flow -257 -401.21 -71.82 -395.84 -147.71
Financing Cash Flow -142.8 -216.79 -581.79 -637.38 -638.72
Net Cash Flow 99.33 8.13 73.13 -85.56 106.96

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Dec 2022% Mar 2023% Jun 2023% Sep 2023%
promoters 74.99 74.99 74.99 74.99 74.99
abbott capital india limi... 50.44 50.44 50.44 50.44 50.44
abbott healthcare product... 17.62 17.62 17.62 17.62 17.62
british colloids limited 6.92 6.92 6.92 6.92 6.92
PARTICULARS Sep 2022% Dec 2022% Mar 2023% Jun 2023% Sep 2023%
investors 25.01 25.01 25.01 25.01 25.01
canara robeco mutual fund... - - - 1.21 1.29
investor education and pr... 0.47 0.47 0.46 0.46 0.50
sbi arbitrage opportuniti... - 1.07 1.12 1.52 1.57
canara robeco mutual fund... - - 1.36 - -
canara robeco mutual fund... - 1.49 - - -
canara robeco mutual fund... 1.29 - - - -
life insurance corporatio... 1.07 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Abbott India - Quaterly Results9 Nov 2023, 1:39PM Abbott India - Quaterly Results9 Nov 2023, 1:39PM Abbott India - Quaterly Results9 Nov 2023, 1:39PM Abbott India informs about disclosure 11 Oct 2023, 5:24PM Abbott India informs about details of loss of certificate 16 Aug 2023, 4:22PM Abbott India - Quaterly Results9 Aug 2023, 6:49PM Abbott India - Quaterly Results9 Aug 2023, 6:49PM Abbott India - Quaterly Results19 May 2023, 4:03PM Abbott India - Quaterly Results19 May 2023, 4:03PM Abbott India - Quaterly Results19 May 2023, 4:03PM Abbott India informs about issuance of duplicate share certificate19 May 2023, 11:10AM Abbott India informs about non-applicability of large corporate entity 17 Apr 2023, 12:03PM Abbott India informs about details of loss of certificate1 Mar 2023, 5:19PM Abbott India - Quaterly Results10 Feb 2023, 2:01PM Abbott India - Quaterly Results10 Feb 2023, 2:01PM Abbott India - Quaterly Results10 Feb 2023, 2:01PM Abbott India informs about disclosure of related party transactions25 Nov 2022, 5:18PM Abbott India informs about issuance of duplicate share certificate 16 Nov 2022, 5:12PM Abbott India informs about press release15 Nov 2022, 12:15PM Abbott India - Quaterly Results14 Nov 2022, 1:17PM Abbott India - Quaterly Results14 Nov 2022, 1:17PM Abbott India - Quaterly Results14 Nov 2022, 1:17PM Abbott India informs about issuance of duplicate share certificates21 Oct 2022, 12:38PM Abbott India informs about issuance of duplicate share certificate20 Oct 2022, 12:32PM Abbott India informs about loss of share certificates19 Oct 2022, 11:49AM Abbott India informs about press release11 Oct 2022, 4:58PM Abbott India informs about analyst meet26 Sep 2022, 5:10PM Abbott India informs about voting results 11 Aug 2022, 12:19PM Abbott India - Quaterly Results10 Aug 2022, 5:39PM Abbott India - Quaterly Results10 Aug 2022, 5:39PM Abbott India reports 39% rise in Q4 net profit18 May 2022, 12:08PM Abbott India - Quaterly Results17 May 2022, 2:32PM Abbott India - Quaterly Results17 May 2022, 2:32PM Abbott India - Quaterly Results17 May 2022, 2:32PM Abbott India informs about issuance of duplicate share certificates27 Apr 2022, 4:44PM Abbott India informs about issuance of duplicate share certificate27 Apr 2022, 10:03AM Abbott India informs about issuance of duplicate share certificate26 Apr 2022, 9:36AM Abbott launches Arachitol Gummies in India11 Apr 2022, 4:58PM Abbott India informs about unaudited financial results9 Feb 2022, 3:45PM Abbott India - Quaterly Results9 Feb 2022, 2:11PM Abbott India - Quaterly Results9 Feb 2022, 2:11PM Abbott India - Quaterly Results9 Feb 2022, 2:11PM Abbott India informs about certificate7 Jan 2022, 4:08PM Abbott India informs about closure of trading window30 Dec 2021, 3:21PM Abbott India informs about issuance of duplicate share certificate 7 Dec 2021, 4:17PM Abbott India informs about issuance of duplicate share certificates3 Dec 2021, 12:58PM Abbott India informs about certificate6 Oct 2021, 10:42AM Abbott introduces single-dose formulation of carbetocin in India31 Aug 2021, 3:15PM Abbott launches COVID-19 home test kit in India12 Jul 2021, 3:34PM Abbott India informs about newspaper advertisement3 Jul 2021, 3:29PM

Abbott India Stock Price Analysis and Quick Research Report. Is Abbott India an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Abbott India and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Abbott India cash from the operating activity was Rs 893.39 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Abbott India has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Abbott India , the EPS growth was 18.8694264973974 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Abbott India has OPM of 22.5378734765075 % which is a good sign for profitability.
     
  • ROE: Abbott India have a healthy ROE of 32.0657249246409 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Abbott India is Rs 22858. One can use valuation calculators of ticker to know if Abbott India share price is undervalued or overvalued.
Last Updated on:
Brief about Abbott India

Abbott India Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Abbott India Ltd. is a leading pharmaceutical company in India, providing a range of healthcare products and services. In this article, we will provide a comprehensive analysis of Abbott India Ltd. stock from a long-term investor's perspective. We will cover various topics such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Abbott India Ltd. Share Price:

Abbott India Ltd.'s share price is an important indicator of investor sentiment towards the company. The share price is influenced by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s share price and identify any trends or patterns. The company's share price has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. Balance Sheet:

Abbott India Ltd.'s balance sheet provides crucial information about its financial health. The company's assets include investments, receivables, and other assets, while liabilities include borrowings, payables, and other liabilities. Equity includes share capital, reserves, and surplus. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s balance sheet and identify any red flags. The company's balance sheet has shown a stable trend over the past few years, reflecting the company's strong financial position.

Abbott India Ltd. Annual Report:

Abbott India Ltd. releases an annual report every year, which provides detailed information about the company's financial performance, strategic initiatives, and future plans. The annual report includes a letter from the Chairman, financial statements, and management discussion and analysis. Long-term investors can download Abbott India Ltd.'s annual report from our website and use it to make informed investment decisions. The annual report provides valuable insights into the company's operations and financial performance.

Abbott India Ltd. Dividend:

Abbott India Ltd. has a consistent dividend payout history. The company has been paying dividends regularly, reflecting the company's strong financial position. Long-term investors should consider this when evaluating Abbott India Ltd.'s stock. Our pre-built screening tools can be used to analyze the company's dividend history and identify any trends or patterns.

Abbott India Ltd. Quarterly Results:

Abbott India Ltd. releases its quarterly results every three months. The quarterly results provide information about the company's revenue, earnings, and expenses. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s quarterly results and identify any trends or patterns. The quarterly results are an important indicator of the company's financial health and performance.

Abbott India Ltd. Stock Price:

The stock price of Abbott India Ltd. is affected by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to track Abbott India Ltd.'s stock price and identify potential buying opportunities. The stock price of Abbott India Ltd. has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. Price Chart:

A price chart provides a visual representation of a company's stock price over a period of time. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s price chart and identify any trends or patterns. The price chart shows that the stock price of Abbott India Ltd. has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. News:

Keeping up to date with the latest news about Abbott India Ltd. is important for investors. Our website provides the latest news about Abbott India Ltd. from various sources such as financial news websites and social media. Long-term investors can use this information to make informed investment decisions.

Abbott India Ltd. Concall:

Abbott India Ltd. holds conference calls with analysts and investors to discuss its financial performance and future plans. Long-term investors can listen to Abbott India Ltd.'s concall and use the information provided to make informed investment decisions. Our website provides information about upcoming concalls and links to listen to past concalls.

Abbott India Ltd. Transcripts:

Transcripts of Abbott India Ltd.'s concalls are available on our website. Long-term investors can download the transcripts and use them to analyze the company's financial performance and future plans. The transcripts provide valuable insights into the company's operations and financial performance.

Abbott India Ltd. Investor Presentations:

Abbott India Ltd. provides investor presentations on its website. These presentations provide information about the company's financial performance, strategic initiatives, and future plans. Long-term investors can download Abbott India Ltd.'s investor presentations from our website and use them to make informed investment decisions. The investor presentations provide valuable insights into the company's operations and financial performance.

Abbott India Ltd. Promoters:

Promoters are individuals or entities that have a significant stake in a company. Abbott India Ltd.'s promoters include Abbott Laboratories and Abbott Healthcare Pvt. Ltd. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s promoter holdings and identify any potential conflicts of interest. The promoter holdings of Abbott India Ltd. are relatively stable, which is a positive sign for long-term investors.

Abbott India Ltd. Shareholders:

Abbott India Ltd. has a large number of shareholders, including institutional investors and individual investors. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s shareholder base and identify any potential risks or opportunities. The shareholder base of Abbott India Ltd. is diverse, which is a positive sign for long-term investors.

Abbott India Ltd. Premium Features:

Our website provides premium features tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help long-term investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation.

X